Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 11, 2017, Pages

  Liu, Haoyuan ^a   Zhao, Jia Guo ^b   Li, Yue ^a   Xia, Jun ^c   Zhao, Sai ^c  

^a The Affiliated Chenggong Hospital of Xiamen University   (China)

^b Department of Foot and Ankle Surgery   (China)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL OUTCOME; CLINICAL PROTOCOL; COCHRANE LIBRARY; HETEROTOPIC OSSIFICATION; HIP ARTHROPLASTY; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 85033582907     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012861     Document Type: Article

References (37)

1. Andreu Martinez FJ, Martinez Mateu JM, Tormo Ferrero V. The role of radiotherapy for prevention of heterotopic ossification after major hip surgery. Clinical and Translational Oncology 2007;9(1):28-31. [PUBMED: 17272227]
2. Bal BS, Lowe JA, Gietler AE, Aleto TJ. Heterotopic ossification after 2-incision total hip arthroplasty. Journal of Arthroplasty 2010;25(4):538-40. [PUBMED: 19497706]
3. Barry S. Non-steroidal anti-inflammatory drugs inhibit bone healing: a review. Veterinary and Comparative Orthopaedics and Traumatology 2010;23(6):385-92.
4. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology 1988;15(12):1833-40. [PUBMED: 3068365]
5. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315(7108):600.
6. Borer JS, Simon LS. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. Arthritis Research and Therapy 2005;7(Suppl 4):S14-22. [PUBMED: 16168077]
7. Bozimowski G. A review of nonsteroidal anti-inflammatory drugs. AANA Journal 2015;83(6):425-33. [PUBMED: 26742337]
8. Bragdon B, Lam S, Aly S, Femia A, Clark A, Hussein A, et al. Earliest phases of chondrogenesis are dependent upon angiogenesis during ectopic bone formation in mice. Bone 2017;101:49-61. [PUBMED: 28412469]
9. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. The Journal of Bone and Joint Surgery. American Volume 1973;55(8):1629-32.
10. Cohn RM, Schwarzkopf R, Jaffe F. Heterotopic ossification after total hip arthroplasty. American Journal of Orthopedics 2011;40(11):E232-5. [PUBMED: 22263220]
11. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD001160.pub3]
12. Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149(9):876-83.
13. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. The Journal of Bone and Joint Surgery. American Volume 1969;51(4):737-55. [PUBMED: 5783851]
14. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
15. Kienapfel H, Koller M, Wust A, Sprey C, Merte H, Engenhart-Cabillic R, et al. Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Archives of Orthopaedic and Trauma Surgery 1999;119(5-6):296-302. [PUBMED: 10447627]
16. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. The Journal of Bone and Joint Surgery. British Volume 1997;79(4):596-602. [PUBMED: 9250745]
17. Lavernia CJ, Contreras JS, Villa JM, Rossi MD. Celecoxib and heterotopic bone formation after total hip arthroplasty. Journal or Arthroplasty 2014;29(2):390-2.
18. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
19. Lussier A, de Medicis R. Correlation between ossification and inflammation using a rat experimental model. The Journal of Rheumatology. Supplement 1983;11:114-7.
20. Macfarlane RJ, Ng BH, Gamie Z, El Masry MA, Velonis S, Schizas C, et al. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opinion on Pharmacotherapy 2008;9(5):767-86. [PUBMED: 18345954]
21. Makins R, Ballinger A. Gastrointestinal side effects of drugs. Expert Opinion on Drug Safety 2003;2(4):421-9.
22. Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis?. Journal of Bone and Joint Surgery. American Volume 2006;88 Suppl 3:140-7.
23. Pohl F, Seufert J, Tauscher A, Lehmann H, Springorum HW, Flentje M, et al. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty. Strahlentherapie und Onkologie 2005;181(8):529-33. [PUBMED: 16044221]
24. Rapuano BE, Boursiquot R, Tomin E, Macdonald DE, Maddula S, Raghavan D, et al. The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model. Archives of Orthopaedic and Trauma Surgery 2008;128(3):333-44.
25. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
26. Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. Journal of Bone and Joint Surgery. American Volume 1988;70(6):834-8.
27. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. Journal of Bone and Mineral Research 2002;17(6):963-76.
28. Siopack JS, Jergesen HE. Total hip arthroplasty. Western Journal of Medicine 1995;162(3):243-9. [PUBMED: 7725707]
29. Spinarelli A, Patella V, Petrera M, Abate A, Pesce V, Patella S. Heterotopic ossification after total hip arthroplasty: our experience. Musculoskeletal Surgery 2011;95(1):1-5. [PUBMED: 21210261]
30. Su B, O'Connor JP. NSAID therapy effects on healing of bone, tendon, and the enthesis. Journal of Applied Physiology 2013;115(6):892-9.
31. Sulek M, Steinbrich-Zoller M, Dudek A, Jancelewicz J, Niedzialek D. Role of non-steroidal anti-inflammatory drugs on upper gastrointestinal bleeding [Niesteroidowe leki przeciwzapalne jako przyczyna krwawien z gornego odcinka przewodu pokarmowego]. Polski Merkuriusz Lekarski 2005;19(113):642-5.
32. Tippets DM, Zaryanov AV, Burke WV, Patel PD, Suarez JC, Ely EE, et al. Incidence of heterotopic ossification in direct anterior total hip arthroplasty: a retrospective radiographic review. Journal of Arthroplasty 2014;29(9):1835-8. [PUBMED: 24957801]
33. Trnka HJ, Zenz P, Zembsch A, Easley M, Ritschl P, Salzer M. Stable bony integration with and without short-term indomethacin prophylaxis. A 5-year follow-up. Archives of Orthopaedic and Trauma Surgery 1999;119(7-8):456-60. [PUBMED: 10613239]
34. Vasileiadis GI, Sakellariou VI, Kelekis A, Galanos A, Soucacos PN, Papagelopoulos PJ, et al. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or indomethacin?. Journal of Musculoskeletal and Neuronal Interactions 2010;10(2):159-65. [PUBMED: 20516633]
35. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83. [PUBMED: 1593914]
36. Wurnig C, Schwameis E, Bitzan P, Kainberger F. Six-year results of a cementless stem with prophylaxis against heterotopic bone. Clinical Orthopaedics and Related Research 1999;361:150-8. [PUBMED: 10212608]
37. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. Journal of Clinical Investigation 2002;109(11):1405-15.